{"transactions":[{"id":800002,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-04-27T20:23:36.000Z","date":"2026-04-23","kind":"grant","planned":false,"acquired":true,"shares":9999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027."}],"balance_after":73067,"source":{"system":"sec-edgar","filing":"0001408228-26-000002","document":"wk-form4_1777321413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000140822826000002/wk-form4_1777321413.xml","form_type":"4"}},{"id":1133272,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-05-27T20:59:37.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":7582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026."}],"balance_after":63068,"source":{"system":"sec-edgar","filing":"0001398659-25-000071","document":"wk-form4_1748379570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000139865925000071/wk-form4_1748379570.xml","form_type":"4"}},{"id":1526221,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-06T20:22:35.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2024 and will be settled in common shares on December 31, 2025."}],"balance_after":55486,"source":{"system":"sec-edgar","filing":"0001398659-24-000067","document":"wk-form4_1715026930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000139865924000067/wk-form4_1715026930.xml","form_type":"4"}},{"id":1886720,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-05-18T12:00:12.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":36.5992,"value":18299.6,"ownership":{"direct":true},"balance_after":44947,"source":{"system":"sec-edgar","filing":"0001140361-23-025388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036123025388/form4.xml","form_type":"4"}},{"id":1886719,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-05-18T12:00:12.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":36.9291,"value":73858.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $36.54 to $37.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range."}],"balance_after":44447,"source":{"system":"sec-edgar","filing":"0001140361-23-025388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036123025388/form4.xml","form_type":"4"}},{"id":1900820,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-05-08T20:12:54.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":7865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024."}],"balance_after":42447,"source":{"system":"sec-edgar","filing":"0001140361-23-023500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036123023500/form4.xml","form_type":"4"}},{"id":2259874,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-05-23T20:19:21.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":7726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2022 and will be settled in common shares on December 31, 2023."}],"balance_after":34582,"source":{"system":"sec-edgar","filing":"0001567619-22-011512","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000156761922011512/doc1.xml","form_type":"4"}},{"id":2722938,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:11:05.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":6252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.  Each RSU entitles the holder to receive one common share at a future date.  Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2021 and will be settled in common shares on December 31, 2022."}],"balance_after":26856,"source":{"system":"sec-edgar","filing":"0001567619-21-009306","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000156761921009306/doc1.xml","form_type":"4"}},{"id":2895109,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-25","kind":"other","acquired":true,"shares":11109,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":188766,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895108,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-25","kind":"other","acquired":false,"shares":22218,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":177657,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895107,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-25","kind":"other","acquired":true,"shares":54939,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the \"Trust\"), of which the reporting person is the trustee."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the \"Trust\"), of which the reporting person is the trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":199875,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895106,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-25","kind":"other","acquired":false,"shares":109878,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the \"Trust\"), of which the reporting person is the trustee."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the \"Trust\"), of which the reporting person is the trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":144936,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895105,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":1674,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":254814,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895104,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":487608,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. (\"CIFII\") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the \"Distribution\"). CIFII no longer holds any shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. (\"CIFII\") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the \"Distribution\"). CIFII no longer holds any shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":256488,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895103,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":487608,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. (\"CIF\") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. (\"CIF\") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":744096,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895102,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":true,"shares":20491,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. (\"CCP\") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. (\"CCP\") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":1231704,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895101,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":2075349,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. (\"CCP\") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. (\"CCP\") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":1211213,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895100,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":6682,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. (\"CCFF\") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. (\"CCFF\") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":3286562,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895099,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":true,"shares":3401,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the \"Common Stock\") held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC (\"CMP\"), CCAF's general partner."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the \"Common Stock\") held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC (\"CMP\"), CCAF's general partner."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":3293244,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":2895098,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"other":true,"other_text":"Fomer Director"}}],"security":"Common Stock","published_at":"2021-01-26T18:44:50.000Z","date":"2021-01-22","kind":"other","acquired":false,"shares":341153,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the \"Common Stock\") held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC (\"CMP\"), CCAF's general partner."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the \"Common Stock\") held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC (\"CMP\"), CCAF's general partner."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"CMP is the general partner of each of CCAF, CCFF and CCP (the \"CMP Group\"). CMPII is the general partner of each of CIF and CIFII (the \"CMPII Group\"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":3289843,"source":{"system":"sec-edgar","filing":"0000898432-21-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843221000070/form4.xml","form_type":"4"}},{"id":3086403,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Warrants","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":101600,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3086402,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Series E Preferred Stock","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":419076,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3086401,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Series D Preferred Stock","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":1424360,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3086400,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Series C Preferred Stock","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":4784,"ownership":{"direct":false,"nature":"By James C. Madden V. Living Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3086399,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Series B Preferred Stock","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":12946,"ownership":{"direct":false,"nature":"By James C. Madden V. Living Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3086398,"issuer":{"id":80959,"kind":"organization","name":"Accolade, Inc.","symbol":"ACCD"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-08T18:57:47.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":3530996,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of the Issuer's Common Stock (\"Common Stock\") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the \"Trust\") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. (\"CCFF\"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. (\"CCP\"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. (\"CIF\") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. (\"CIFII\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Issuer's Series B Preferred Stock (the \"Series B Preferred\") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the \"Charter\") and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the \"Series C Preferred\") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the \"Series D Preferred\") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the \"Series E Preferred\") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares of the Issuer's Common Stock (\"Common Stock\") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the \"Trust\") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. (\"CCFF\"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. (\"CCP\"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. (\"CIF\") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. (\"CIFII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares of the Issuer's Common Stock (\"Common Stock\") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the \"Trust\") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. (\"CCAF\"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. (\"CCFF\"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. (\"CCP\"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. (\"CIF\") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. (\"CIFII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Carrick Management Partners, LLC (\"CMP\" and, together with CCAF, CCFF and CCP, the \"CMP Group\") is the general partner of each of CCAF, CCFF and CCP. Carrick Management Partners II, LLC (\"CMPII\" and, together with CIF and CIFII, the \"CMPII Group\") is the general partner of each of CIF and CIFII. CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":3630996,"source":{"system":"sec-edgar","filing":"0000898432-20-000645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1481646/000089843220000645/form4.xml","form_type":"4"}},{"id":3137004,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-05-22T20:06:35.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":8617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.  Each RSU entitles the holder to receive one common share at a future date.  Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2020 and will be settled in common shares on December 31, 2021."}],"balance_after":20604,"source":{"system":"sec-edgar","filing":"0001567619-20-010993","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000156761920010993/doc1.xml","form_type":"4"}},{"id":3529643,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-05-13T20:19:34.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":3326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.  Each RSU entitles the holder to receive one common share at a future date.  Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020."}],"balance_after":11987,"source":{"system":"sec-edgar","filing":"0001567619-19-010574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000156761919010574/doc1.xml","form_type":"4"}},{"id":3938791,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-05-10T20:27:47.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":3961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.  Each RSU entitles the holder to receive one common share at a future date.  Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2018 and will be settled in common shares on December 31, 2019."}],"balance_after":8661,"source":{"system":"sec-edgar","filing":"0001140361-18-022798","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036118022798/doc1.xml","form_type":"4"}},{"id":4051721,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-02-16T21:03:32.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":4270,"price":30.9218,"value":132036.086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price.  The actual sales prices for these transactions ranged from $30.9201 to $30.922.  The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0001140361-18-008811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036118008811/doc1.xml","form_type":"4"}},{"id":4320686,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-05-15T20:09:17.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":5224,"price":25.5146,"value":133288.2704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price.  The actual sales prices for these transactions ranged from $25.41 to $25.59.  The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":8970,"source":{"system":"sec-edgar","filing":"0001140361-17-020653","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036117020653/doc1.xml","form_type":"4"}},{"id":4324652,"issuer":{"id":3760,"kind":"organization","name":"Genpact LTD","symbol":"G"},"owners":[{"id":51163,"kind":"person","name":"Madden James C.","position":1,"cik":"0001408228","reported_name":"Madden James C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-05-11T20:09:44.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.  Each RSU entitles the holder to receive one common share at a future date.  Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2017 and will be settled in common shares on December 31, 2018."}],"balance_after":14194,"source":{"system":"sec-edgar","filing":"0001140361-17-019745","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408228/000114036117019745/doc1.xml","form_type":"4"}}]}